A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies

Trial Profile

A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs CLR 1404 I-124 (Primary)
  • Indications Breast cancer; Colorectal cancer; Gastric cancer; Head and neck cancer; Male breast cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Soft tissue sarcoma
  • Focus Diagnostic use
  • Most Recent Events

    • 16 May 2016 Status changed from active, no longer recruiting to discontinued as sponsor determined this trial does not support their anticipated clinical development program.
    • 21 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 30 Apr 2015 Status changed from suspended to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top